United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Healthcare Industry News ACR 2025: Dr. Sabine Grimm explains why HTA is vital for advancing rheumatology access and equity Discover how HTA is reshaping rheumatology delivery. Dr. Sabine Grimm explains how value-based assessment improves care, access, and affordability. byPallavi MadhirajuOctober 25, 2025